Adapting BA for Minimally Verbal Autistic Adults
Adaptation of a Behavioral Activation Treatment to Treat Depression in Autistic Adults
1 other identifier
interventional
9
1 country
1
Brief Summary
The present study aims to adapt and evaluate the feasibility of the BeatIt-2 behavioral activation intervention for people with intellectual disabilities and low mood to be implemented with minimally verbal autistic individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2023
CompletedFirst Posted
Study publicly available on registry
October 3, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedMay 4, 2026
April 1, 2026
1.8 years
September 25, 2023
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Glasgow Depression Scale for Intellectual Disability (GDS)
The GDS is a 20-item self- and caregiver-reported questionnaire of psychological function over the past week with all items on a "0" (Never/No) to 2 (Always/A lot) scale. Higher scores equal more distress. Scores range from 0-32. The expected change is a decrease in the score.
Week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)
Anxiety Depression and Mood Scale (ADAMS)
The ADAMS is a 20-item caregiver-reported questionnaire of psychological function over the past week with all items on a "0" (Never/No) to 2 (Always/A lot) scale. Higher scores equal more distress. Total scores range from 0-84. The expected change is a decrease in the score.
Week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)
Mood, Interest, & Pleasure Questionnaire (MIPQ)
The MIPQ is a 25-item caregiver-reported questionnaire of behaviors over the past week with all items on a "0" (Never) to 4 (All the time) scale. Higher scores equal more distress. Total scores range from 0-100. The expected change is a decrease in the score.
Week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)
Secondary Outcomes (2)
Vineland Adaptive Behavior Scale, 3rd edition (VABS-3)
Week 1 (initial assessment) to week 22 (follow-up)
Shalock Quality of Life Questionnaire
Week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)
Study Arms (1)
BeatIt-MV Treatment Group
EXPERIMENTALParticipants, along with support persons, will complete 12 weekly sessions of the BeatIt-MV intervention. The support person will complete an initial session before commencement of the 12 weekly sessions.
Interventions
BeatIt-MV, designed to be implemented with minimally verbal autistic individuals, is an adaptation of BeatIt-2. The intervention aims to improve mood and decrease depressive symptoms through an increase in meaningful engagement in recreational, domestic, and social/leisure activities.
Eligibility Criteria
You may qualify if:
- Minimally verbal
- Aged 18 years or older
- Diagnosis of Autism Spectrum Disorder and clinically significant depression based on clinical best estimate diagnosis using DSM-5 or Diagnostic Manual - Intellectual Disability criteria
- Have a support person willing to participate
- Live in New Jersey or New York, or be within travel distance to Rutgers University
You may not qualify if:
- Not able to engage in treatment in English
- current engagement in other treatment for depression
- conditions that may preclude engagement in treatment sessions (e.g., active psychosis, unmanaged seizures)
- high suicide risk (i.e., with a clear plan, expressed intent or recent documented attempts)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rutgers University - New Brunswick
Piscataway, New Jersey, 08854, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vanessa Bal, PhD
Rutgers University - New Brunswick
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor; Karmazin & Lillard Chair in Adult Autism, Rutgers, The State University of New Jersey
Study Record Dates
First Submitted
September 25, 2023
First Posted
October 3, 2023
Study Start
November 1, 2023
Primary Completion
August 30, 2025
Study Completion
August 30, 2025
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share